Learning Activity 1: Self Assessment, Evaluation, and Credit Application Form

Please note that to receive credit you must achieve a score of at least 80%.

Physicians/Physician Assistants: Certificate of Credit will be emailed within 4 weeks of successful completion of the activity.

Pharmacists: The information that you participated will be uploaded to CPE Monitor and you will be able to access your credits from the profile you set up with NABP. For more information, please visit http://www.nabp.net/.

Question Title

1. Over the past few years, the greatest increase in the incidence of C. difficile infection has been observed in:

Female patients.

Patients ≥65 years of age.

Patients from the Midwest region of the US.

Young adults.

Question Title

2. Risk factors for C. difficile infections include all of the following except:

Prior antimicrobial usage.

Advanced age.

Prolonged length of stay in the hospital.

Exposure to child care facilities.

Question Title

3. The primary driver of costs associated with C. difficile infection is:

Hospital length of stay.

Antimicrobial therapy.

Surgery.

Added infection control measures.

Question Title

4. The use of which antimicrobial is associated with the highest risk of C. difficile infection?

Clindamycin

Azithromycin

Metronidazole

Tigecycline

Question Title

5. First-line treatment of mild-to-moderate C. difficile infection in the pediatric population is:

Oral metronidazole.

Oral vancomycin.

Oral moxifloxacin.

Oral metronidazole plus IV vancomycin.